Agriculture and Natural ... Quote - ANSCU | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Agriculture and Natural Solutions Acquisition Corporation (ANSCU) Share Price

Agriculture and Natural Solutions Acquisition Corporation (ANSCU)

10.30

0.00

(0.00%)

Closed June 29 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: 3:00PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

10.30

Bid

4.13

Ask

16.49

Volume

-

0.00 Day's Range 0.00

10.04 52 Week Range 11.93

Market Cap

Previous Close

10.30

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

2,085

Shares Outstanding

30,000,000

Dividend Yield

-

PE Ratio

235.40

Earnings Per Share (EPS)

0.04

Revenue

-

Net Profit

1.31M

Sector

Blank Checks

Industry

Blank Checks

Headquarters

New York, New York, USA

Founded

1970

Agriculture and Natural Solutions Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker ANSCU. The last closing price for Agriculture and Natural ... was US$10.30. Over the last year, Agriculture and Natural ... shares have traded in a share price range of US$ 10.04 to US$ 11.93.

Agriculture and Natural ... currently has 30,000,000 shares outstanding. The market capitalization of Agriculture and Natural ... is US$307.20 million. Agriculture and Natural ... has a price to earnings ratio (PE ratio) of 235.40.

Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024

Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024 PR Newswire NEW YORK, Jan. 2...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-0.386847195358	10.34	10.34	10.29	2916	10.3	CS
4	-0.02	-0.193798449612	10.32	10.45	10.29	895	10.30238186	CS
12	0.02	0.194552529183	10.28	11.93	10.24	2085	10.31453245	CS
26	0.15	1.47783251232	10.15	11.93	10.11	4409	10.21808132	CS
52	0.25	2.48756218905	10.05	11.93	10.04	104349	10.0792259	CS
156	0.25	2.48756218905	10.05	11.93	10.04	104349	10.0792259	CS
260	0.25	2.48756218905	10.05	11.93	10.04	104349	10.0792259	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DNDelta 9 Cannabis Inc	$ 0.015 (50.00%)	1.1M
BRMIBoat Rocker Media Inc	$ 1.02 (29.11%)	1.84M
TSATTelesat Corporation	$ 12.50 (17.26%)	3.24k
QECQuesterre Energy Corporation	$ 0.25 (16.28%)	24.6k
GEOGeodrill Limited	$ 2.30 (15.58%)	47.28k
NCPNickel Creek Platinum Corp	$ 0.01 (-33.33%)	1.07k
LPENLoop Energy Inc	$ 0.025 (-28.57%)	73.62k
ASNDAscendant Resources Inc	$ 0.035 (-22.22%)	1,000
FLNTFlint Corporation	$ 0.025 (-16.67%)	16.5k
BNGBengal Energy Ltd	$ 0.03 (-14.29%)	85k
TRPTC Energy Corporation	$ 51.87 (-1.76%)	34.35M
BNSBank of Nova Scotia	$ 62.58 (0.29%)	18.9M
POWPower Corp of Canada	$ 38.02 (-1.66%)	13.19M
TDToronto Dominion Bank	$ 75.20 (0.09%)	9.87M
MFCManulife Financial Corporation	$ 36.44 (0.41%)	6.48M

Smartypants2

Smartypants2 58 seconds ago

That Australian construction panel Killa found is very different from NEXBOARD. Look at the board being fire tested on XERIANT.com. It's white, not multi-colored. And it's fire-resistant. They are obviously produced very differently and have very different qualities.

King23

King23 1 minute ago

His timing is above most who can understand. The timing is brilliant.

MrPuff

MrPuff 1 minute ago

Once the float gets locked up, this thing will move 1 penny at a time....and pretty quickly.

With this SS, convertible notes exercised at $1, the type of insiders involved with this company, and the way they are releasing news has all the earmarks of a big runner.

Back

georgejjl

georgejjl 3 minutes ago

From the New York Times

HEALTH
Embattled Alzheimer’s Researcher Is Charged With Fraud
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.

Good luck and GOD bless,

al44

al44 3 minutes ago

Joe Biden is not the problem

By Earick Ward

It is not Joe’s policies that have failed the American people. It is leftism writ large.

The CNN roundtable after the debate was comical, if not tragic. For months (years) Republicans have been asserting

Vettelover98

Vettelover98 3 minutes ago

Do you know how to contact the TA?

rooster

rooster 3 minutes ago

So because CNN didn’t stake the deck for Joe, they did a bad job and are now on the republicans side? Wow! Cry much do we.

Vettelover98

Vettelover98 3 minutes ago

That’s my hope.. it would be helpful if someone had that contact info for the TA.. do you?

ilovetech

ilovetech 3 minutes ago

Once the first approval is "cemented," NWBO can justify a "media blitz." The dissemination of information will see rebalancing, leading low budget trolls to share basement space. I expect AF to have a hit piece already locked and loaded to release on news of the approval. He's done it before. He wil

learningcurve2020

learningcurve2020 4 minutes ago

These docs went from treating mice to patients during the time L was in data lock.

>>“To accomplish this trial, we needed experts in cell therapy — people who are administering it routinely, who understand how it works in the body, how people respond to it, and we have a wholesale c

splintered sunlight

splintered sunlight 4 minutes ago

That would be nice.

zab

zab 5 minutes ago

Once again, the only person you are supposed to improve, is yourself.

mmayr

mmayr 5 minutes ago

**Interesting Dialogue on Inforwars.com @ (See Below)

https://www.infowars.com/posts/jack-posobiec-issues-emergency-warning-biden-planning-wwiii-as-october-surprise-us-faces-total-destabilization-civil-war-must-watch/

al44

al44 5 minutes ago

Five actions by Democrats which sunk Ukraine

By Fred Farrokh

American hegemony is in question. American weakness has emboldened Russia, Iran, China, and North Korea.

Observers of American support for Ukraine would likely consider the Democrats to be pro-U

prototype_101

prototype_101 6 minutes ago

TFLN? here worth another LQQk,

TFLN isn’t ready. Unless HyperLight drastically expanded their production line and figured out their stability issues, they aren’t able to supply the market.

Liobate. No. Luxtelligence and it’s customers. No. Lightium is the new guy. No,

Truth and Transparency

Truth and Transparency 7 minutes ago

You’re actually living in denial

splintered sunlight

splintered sunlight 8 minutes ago

I've been patient, I am patient and I will be patient.

Approval is everything.

LOOKING FORWARD!!!!!!!!!!!!

mick

mick 8 minutes ago

https://investocracy.com/the-1-5-billion-thames-barrier-keeping-london-from-flooding/

HD2001

HD2001 9 minutes ago

I hope you're right because the dump will be 175 million or they wouldn't have raised the authorized.

ysung

ysung 10 minutes ago

No way Dave would send such confirmation by Email if it is not true !!!!

I would not for sure !!!

quester614

quester614 10 minutes ago

That was a good find on SCAMBOARDS. Duffy shouldn't have let that PPA expire. LOLOLOLOL

rbl100

rbl100 11 minutes ago

Check out this site for videos of people dropping dead on camera from the VAXX. The MSM ignores them all. Of course they would. They know full well what is happening.
https://rumble.com/user/CovidBC

Doc logic

Doc logic 11 minutes ago

learningcurve2020,

Ooops!; ). You forgot to mention all the fights that are won on a daily basis to keep us alive until we become immuno compromised or until the aging gene kicks in and reduces our ability to maintain vigilance or attack. When immune function or surveillance drops

gdog

gdog 12 minutes ago

Zacks
Netlist (NLST) Wins $445 Million in Patent Violation Case
Zacks Equity Research
Tue, May 28, 20243 min read

2
In This Article:
MU
-0.53%
NLST
0.00%
ANET
+0.73%
Netlist, Inc. NLST recently announced a le

Agriculture and Natural ...

FlexiInternational Softw... (CE)

Arthur J Gallagher

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions